Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalEtoposideHodgkin DiseaseCyclophosphamideLymphoma, Non-HodgkinMyeloablative AgonistsRecurrenceCytarabineCarmustineSurvival RateHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaVincristineBone Marrow PurgingSurvival AnalysisHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationRetrospective StudiesAmyloidosisDoxorubicinHematopoietic Stem CellsPrognosisBusulfanBoronic AcidsDexamethasonePyrazinesAntineoplastic AgentsGraft SurvivalFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents, AlkylatingLymphoma, FollicularAntigens, CD34Time FactorsAutograftsLymphoma, T-Cell, PeripheralLiver TransplantationThalidomideIfosfamideInduction ChemotherapyLymphomaMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisPrednisonePodophyllotoxinNeoplasm, ResidualLymphoma, Large B-Cell, DiffuseTransplantation ChimeraMaintenance ChemotherapyNeoplasmsTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationCell TransplantationAntibodies, MonoclonalLymphoma, B-CellKidney TransplantationEmbryonic Stem CellsEnteropathy-Associated T-Cell LymphomaMyelodysplastic SyndromesMitoxantroneIdarubicinCisplatinNeoplasms, Second PrimaryLeukemia, Plasma CellInfusions, SpinalProspective StudiesImmunotherapyNeoplasm Recurrence, LocalCarboplatinAdult Stem CellsChemotherapy, AdjuvantBlood Component RemovalImmunosuppressive AgentsHistocompatibility TestingFeasibility StudiesDrug Administration ScheduleCell DifferentiationFatal OutcomeBreast NeoplasmsCell Line, TumorLeukemia, Myeloid